Lv4
405 积分 2021-08-24 加入
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
15天前
已完结
Anti‐oncostatin M antibody inhibits the pro‐malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma
24天前
已完结
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma
24天前
已完结
Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage
24天前
已完结
Oncostatin M and its role in fibrosis
24天前
已完结
Correction to Lancet Gastroenterol Hepatol 2025; 10: 715–25
1个月前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
1个月前
已完结
Establishing a flow cytometry‐based tissue receptor occupancy assay for an anti‐oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease
1个月前
已完结
Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95
1个月前
已完结
The ever-expanding role of cytokine receptor DR3 in T cells
1个月前
已完结
皖公网安备34019202002308
